MedTrace Logo

Endo-ePIcardial Versus Endocardial Only Catheter Ablation for ISchemic Driven Ventricular Tachycardia (EPISODE VT)

NCT07240441 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2025-11-20

No results posted yet for this study

Summary

The EPISODE VT trial is designed to compare efficacy and safety of two modalities for interventional treatment - endocardial ablation and endo-epicardial ablation in a population of patients with post myocardial infarction (ICD 10 - I25.2) ventricular tachycardias (ICD 10 - I47.2), who are protected by an implantable cardioverter-defibrilator (ICD) and meet study inclusion criteria.

Conditions

  • Ventricular Tachycardias
  • Myocardial Infarction (MI)
  • Implantable Cardiac Defibrillator
  • Ablation

Interventions

PROCEDURE

Endo-epicardial VT ablation

Post-myocardial infarction VT radiofrequency ablation using an endo-epicardial approach with pericardial sac puncture preceded by CO2 insufflation

PROCEDURE

Endocardial VT ablation

Post-myocardial infarction VT radiofrequency ablation using a standard endocardial approach

Sponsors & Collaborators

  • National Institute of Cardiology, Warsaw, Poland

    collaborator OTHER

  • Medical University of Warsaw

    collaborator OTHER

  • MEDICOVER SP Z O.O.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-03
Primary Completion
2030-11-30
Completion
2030-11-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07240441 on ClinicalTrials.gov